In mouse models, fibroblast-specific Prrx1 deletion led to more differentiated, less metastatic tumours, alongside changes to the tumour ECM, and this phenotype was attributed to release of hepatocyte growth factor (HGF) driving EMT in tumour cells [64]. The gene discussed is PRRX1; the disease is neoplasm.